- α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
 
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2017-02-25)
Sandra Heskamp, Reinier Hernandez, Janneke D M Molkenboer-Kuenen, Markus Essler, Frank Bruchertseifer, Alfred Morgenstern, Erik J Steenbergen, Weibo Cai, Christof Seidl, William J McBride, David M Goldenberg, Otto C Boerman
PMID28232604
ABSTRACT
Pretargeted radioimmunotherapy (PRIT) with the β-emitting radionuclide